Palbociclib in Patients With Ovarian Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Saved in:
| Title: | Palbociclib in Patients With Ovarian Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study. |
|---|---|
| Authors: | Veljovich DS; Swedish Cancer Institute, Seattle, WA., Rothe M; American Society of Clinical Oncology, Alexandria, VA., Garrett-Mayer E; American Society of Clinical Oncology, Alexandria, VA., Ali-Ahmad HM; Michigan Cancer Research Consortium, Lansing, MI., Naumann RW; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC., Siedel J; University of Michigan, Ann Arbor, MI., Chan JK; Sutter Cancer Research Consortium, San Francisco, CA., Gregory A; Advocate Aurora Healthcare, Milwaukee, WI., Pisick E; City of Hope Chicago, Zion, IL., Adesunloye B; City of Hope Atlanta, Atlanta, GA., Arend RC; Division of Gynecologic Oncology, O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, Birmingham, AL., Bell M; Sanford Health, Sioux Falls, SD., Frimer M; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Northwell Health, Northwell Health Cancer Institute, New Hyde Park, NY., Tawfik B; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM., Thota R; Intermountain Healthcare, Murray, UT., Tsimberidou AM; The University of Texas MD Anderson Cancer Center, Houston, TX., Mangat PK; American Society of Clinical Oncology, Alexandria, VA., Hinshaw DC; American Society of Clinical Oncology, Alexandria, VA., Gregory A; American Society of Clinical Oncology, Alexandria, VA., Grantham GN; American Society of Clinical Oncology, Alexandria, VA., Halabi S; Duke University Medical Center, Durham, NC., Schilsky RL; American Society of Clinical Oncology, Alexandria, VA. |
| Source: | JCO precision oncology [JCO Precis Oncol] 2026 Jul; Vol. 10 (7), pp. e2600456. Date of Electronic Publication: 2026 Jul 15. |
| Publication Type: | Journal Article; Clinical Trial, Phase II |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42456088 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Palbociclib in Patients With Ovarian Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Veljovich+DS%22">Veljovich DS</searchLink>; Swedish Cancer Institute, Seattle, WA.<br /><searchLink fieldCode="AU" term="%22Rothe+M%22">Rothe M</searchLink>; American Society of Clinical Oncology, Alexandria, VA.<br /><searchLink fieldCode="AU" term="%22Garrett-Mayer+E%22">Garrett-Mayer E</searchLink>; American Society of Clinical Oncology, Alexandria, VA.<br /><searchLink fieldCode="AU" term="%22Ali-Ahmad+HM%22">Ali-Ahmad HM</searchLink>; Michigan Cancer Research Consortium, Lansing, MI.<br /><searchLink fieldCode="AU" term="%22Naumann+RW%22">Naumann RW</searchLink>; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC.<br /><searchLink fieldCode="AU" term="%22Siedel+J%22">Siedel J</searchLink>; University of Michigan, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Chan+JK%22">Chan JK</searchLink>; Sutter Cancer Research Consortium, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Gregory+A%22">Gregory A</searchLink>; Advocate Aurora Healthcare, Milwaukee, WI.<br /><searchLink fieldCode="AU" term="%22Pisick+E%22">Pisick E</searchLink>; City of Hope Chicago, Zion, IL.<br /><searchLink fieldCode="AU" term="%22Adesunloye+B%22">Adesunloye B</searchLink>; City of Hope Atlanta, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Arend+RC%22">Arend RC</searchLink>; Division of Gynecologic Oncology, O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, Birmingham, AL.<br /><searchLink fieldCode="AU" term="%22Bell+M%22">Bell M</searchLink>; Sanford Health, Sioux Falls, SD.<br /><searchLink fieldCode="AU" term="%22Frimer+M%22">Frimer M</searchLink>; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Northwell Health, Northwell Health Cancer Institute, New Hyde Park, NY.<br /><searchLink fieldCode="AU" term="%22Tawfik+B%22">Tawfik B</searchLink>; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM.<br /><searchLink fieldCode="AU" term="%22Thota+R%22">Thota R</searchLink>; Intermountain Healthcare, Murray, UT.<br /><searchLink fieldCode="AU" term="%22Tsimberidou+AM%22">Tsimberidou AM</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Mangat+PK%22">Mangat PK</searchLink>; American Society of Clinical Oncology, Alexandria, VA.<br /><searchLink fieldCode="AU" term="%22Hinshaw+DC%22">Hinshaw DC</searchLink>; American Society of Clinical Oncology, Alexandria, VA.<br /><searchLink fieldCode="AU" term="%22Gregory+A%22">Gregory A</searchLink>; American Society of Clinical Oncology, Alexandria, VA.<br /><searchLink fieldCode="AU" term="%22Grantham+GN%22">Grantham GN</searchLink>; American Society of Clinical Oncology, Alexandria, VA.<br /><searchLink fieldCode="AU" term="%22Halabi+S%22">Halabi S</searchLink>; Duke University Medical Center, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Schilsky+RL%22">Schilsky RL</searchLink>; American Society of Clinical Oncology, Alexandria, VA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101705370%22">JCO precision oncology</searchLink> [JCO Precis Oncol] 2026 Jul; Vol. 10 (7), pp. e2600456. <i>Date of Electronic Publication: </i>2026 Jul 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase II – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101705370 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-4284 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224734284%22">24734284 </searchLink><i>NLM ISO Abbreviation: </i>JCO Precis Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42456088 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1200/PO-26-00456 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e2600456 Titles: – TitleFull: Palbociclib in Patients With Ovarian Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Veljovich DS – PersonEntity: Name: NameFull: Rothe M – PersonEntity: Name: NameFull: Garrett-Mayer E – PersonEntity: Name: NameFull: Ali-Ahmad HM – PersonEntity: Name: NameFull: Naumann RW – PersonEntity: Name: NameFull: Siedel J – PersonEntity: Name: NameFull: Chan JK – PersonEntity: Name: NameFull: Gregory A – PersonEntity: Name: NameFull: Pisick E – PersonEntity: Name: NameFull: Adesunloye B – PersonEntity: Name: NameFull: Arend RC – PersonEntity: Name: NameFull: Bell M – PersonEntity: Name: NameFull: Frimer M – PersonEntity: Name: NameFull: Tawfik B – PersonEntity: Name: NameFull: Thota R – PersonEntity: Name: NameFull: Tsimberidou AM – PersonEntity: Name: NameFull: Mangat PK – PersonEntity: Name: NameFull: Hinshaw DC – PersonEntity: Name: NameFull: Gregory A – PersonEntity: Name: NameFull: Grantham GN – PersonEntity: Name: NameFull: Halabi S – PersonEntity: Name: NameFull: Schilsky RL IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2026 Jul Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2473-4284 Numbering: – Type: volume Value: 10 – Type: issue Value: 7 Titles: – TitleFull: JCO precision oncology Type: main |
| ResultId | 1 |